Antidepressants Market:
WiseGuyReports.com adds “Global Antidepressants Market Research Report 2020-30” reports to its database.
Executive Summary
The global antidepressants market is expected to grow from $14.3 billion in 2019 to about $28.6 billion in 2020 as mental health issues are expected to surge due to the effects of the Covid-19 pandemic making an impact on the global economy. The market is expected to stabilize and reach $19 billion at a CAGR of 7.4% through 2023.
The antidepressants market has also surged during the covid-19 outbreak. The increasing number of cases and fatalities is affecting the mental health by elevating anxiety worldwide. People who are already living with mental health problems are experiencing increased stress levels over the Covid-19 outbreak. This has triggered the demand for antidepressant drugs.
The antidepressants market consists of sales of antidepressants and related services that are used in retail pharmacies, hospitals and clinics. Antidepressants are drugs that can help to alleviate depressive symptoms, social anxiety disorder, anxiety disorders, seasonal affective disorder, and dysthymia, or moderate persistent depressive, as well as other conditions. The antidepressant medications available include the antagonists of SSRIs or selective serotonin reuptake, MAOIs or monoamine oxidase inhibitors, tricyclic antidepressants, tetracyclic antidepressants and others.
Request Free Sample Report @ https://www.wiseguyreports.com/sample-request/5226503-antidepressants-global-market-report-2020-30-covid-19
The antidepressants market covered in this report is segmented by product into selective serotonin reuptake inhibitor (SSRI); serotonin-norepinephrine reuptake inhibitor (SNRI); tricyclic antidepressant (TCA); monoamine oxidase inhibitor (MAOI); other products. It is also segmented by drug class into monoamine oxidase inhibitors; serotonin antagonist and reuptake inhibitors; serotonin-norepinephrine reuptake inhibitors; selective serotonin reuptake inhibitors; tricyclic antidepressants; others and by depressive disorder into major depressive disorder; obsessive-compulsive disorder; generalized anxiety disorder; panic disorder; others.
In May 2018, Allergan, an Ireland based company, focused on developing, manufacturing and commercializing branded pharmaceutical, device, biologic, surgical and regenerative medicine products for patients around the world acquired Aptinyx for an unclosed amount. Through this acquisition Allergan gained important insights into NMDA receptor modulation as a potential therapeutic approach for depression. Aptinyx, a clinical-stage biopharmaceutical company focused on the discovery and development of transformative therapies for challenging neurologic disorders.
The side-effects and patent expiry of antidepressant drugs is a key factor hampering the growth of the antidepressant market. The antidepressants are Lexapro (escitalopram) and Celexa (citalopram), both of which are used to treat depression, Lexapro also helps for anxiety. Lexapro and Celexa can cause side effects common to others which includes nausea, sleeplessness, sweating, dry mouth and drowsiness. Celexa and Lexapro are both at risk for even more serious side effects including excessive bleeding, seizures and vision issues. In 2018 the labels of the medications contained a black box warning for an increased suicide risk. Therefore, the side-effects and patent expiry of antidepressant drugs is expected to limit the growth of the antidepressant market.
The treatment for resistant depression is a key trend in the antidepressant market. Ketamine is the new treatment that is used for anesthesia during surgery, stimulates the development of glutamate, and prompts the brain to form new neural connections. It makes the brain more adaptable and capable of developing new pathways and helps people to create more optimistic thoughts and behaviours. In 2018, Food and Drug Administration (FDA) approved ketamine, an anesthetic that has made waves for its surprising antidepressant effect. Since treatment with esketamine may be of great benefit to patients with treatment-resistant depression (meaning conventional therapies have not benefited them), the FDA has speeded up the approval process to make it available more rapidly.
Globally, rising cases of mental health disorders are the key factor in the growth of the antidepressant drug industry, as many customers rely on these medications to counter depression, anxiety disorder etc. Antidepressant medications are used in conditions such as depression, OCD, childhood enuresis, major depressive disorder, severe anxiety disorder, bipolar disorder, post-traumatic stress disorder (PTSD), social anxiety disorder, etc. Globally, the percentage of people with depression varies from 2% to 6% and the elderly are at greater risk of depression relative to other age groups. According to WHO, in 2020, about 264 million people of all ages worldwide suffer from depression. Therefore, rising cases of mental health disorders is expected to drive the growth of the antidepressant market.
Major players in the antidepressants market are Allergan PLC, AstraZeneca, Eli Lilly and Company, GlaxoSmithKline PLC, H. Lundbeck AS, Johnson & Johnson, Pfizer Inc., Merck & Co. Inc., Sanofi, and Sun Pharmaceuticals Pvt Ltd.
Continuous…
For further information on this report, visit – https://www.wiseguyreports.com/reports/5226503-antidepressants-global-market-report-2020-30-covid-19
CONTACT US:
NORAH TRENT
Partner Relations & Marketing Manager
Ph: +1-646-845-9349 (US)
Ph: +44 208 133 9349 (UK)
This report studies the global market size of Colonoscopy in key regions like North America, Europe,Asia Pacific, Central & South America and Middle East & Africa, focuseson the consumption of Colonoscopy inthese regions.
This report also studies the global market status, competitionlandscape, market share, growth rate, future trends, market drivers,opportunities and challenges, sales channels, distributors and Porter’s FiveForces Analysis.
Market size split by Region
Rest of Central & South America
Do Inquiry BeforeAccessing Global Colonoscopy Market Report at https://www.orbisresearch.com/contacts/enquiry-before-buying/2374234 .
Focuses on the key global Colonoscopy manufacturers, to define, describe and analyzethe sales volume, value, market share, market competition landscape, SWOTanalysis and development plans in next few years.
Global “Smart Education Software Market” report analysis worldwide market size in the key regions like Europe, North America, China, Japan, and various regions.
This study classifies the worldwide Software Smart Education breakdown info by makers, region, type, and application, additionally analyses the market standing, rate of growth, market share, future trends, challenges, market drivers, opportunities, risks & entry barriers.
an important analysis of sales channels and distributors, other 5 Forces Analysis.
This report focuses on the highest manufacturers’ good Education software capability, production, value, price, and market share of good Education software within the world market.
the subsequent makers are coated during this report are
Smart Education Software Market by Applications
Telemedicine Market Research Report, By Service Type (Telenursing), Component (Software, Hardware), Deployment (Cloud-Based, On-Premises), Application (Cardiology, Radiology, Dermatology) End Users (Hospitals, Clinics, Home Care) - Global Industry Size, Trends, Growth, Analysis, Share, Forecast till 2023Market HighlightsIncreasing adoption of Electronic Health Record (EHR)/ Electronic Medical Record (EMR), rising prevalence of chronic diseases like diabetes, cancer, besides others followed by a dearth of physicians in the presence of increasing healthcare services demands drives the global telemedicine market.
However, the high cost of implementing telemedicine systems and the need for training along with stringent government regulations is estimated to restraint the market growth during the projected period.Global Telemedicine Market is expected to grow at a CAGR of 16.8% and reach USD 56,738.3 by 2023.SegmentationThe global telemedicine market is segmented on the basis of service type, component, deployment, application, and end user.On the basis of the service type, the market is segmented into telenursing, telepharmacy, teleradiology, teledermatology, teleoncology, others.
On the basis of the deployment, the market is segmented into cloud based and on premises.
On the basis of the end user, the market is segmented into hospitals, clinics, home care.Request Free Sample Copy @ https://www.marketresearchfuture.com/sample_request/2216Regional AnalysisThe Americas dominates the global telemedicine market.
Factors such as the presence of a well-developed healthcare sector and the increasing adoption of healthcare IT drives the market growth within the region.
Europe stands second in the global telemedicine market due to increasing adoption of new technologies in the healthcare sector and increasing government support.
This report studies Beta-Carotene Market with SWOT analysis, Market Share, Restraint analysis, Segmentation, Insights, Growth, Application, Trends, Market driver analysis, Revenue and Competitive analysis in these regions, forecast to 2024.
This report focuses on top manufacturers in Global Market. Global Beta-Carotene Market is predicted to grow considerably in the years to come owing to the impressive increase in the consumption of beta-carotene in different types of foods.
An antioxidant plays important role in normal human growth, development, and eyesight. Beta-carotene also fortifies immune system of the body and has a strong impact on thymus gland where immune cells are produced.
On the other hand, excessive consumption of beta-carotene can adversely affect human body and high cost of supplements may restrain overall market growth in the years to come.
Switching Equipment Market:WiseGuyReports.com adds “Switching Equipment Global Market Report 2020-30” reports to its database.Executive SummaryThe global switching equipment market was worth $191.93 billion in 2019.
In 2019, North America was the largest region in the switching equipment market.The switching equipment market consists of sales of switching equipment and related services.
The switching equipment industry includes establishments that manufacture switching equipment including circuit breakers, contactors, switch disconnectors and disconnectors.Request Free Sample Report @ https://www.wiseguyreports.com/sample-request/5247123-switching-equipment-global-market-report-2020-30-covidThe installation process of network switches is complex as it involves high accuracy and a number of sub-processes, thus hindering the growth of switching equipment market during the historic period.
For instance, in the telecom industry, for telecom network backhaul projects, the installation process can take more than a week to complete.The increase in the popularity of IoT devices among the populace has led to a rise in the switching equipment market.
IoT is becoming popular as a greater number of people are using smart devices and are mostly working on their errands, office work, communication, sending/receiving messages using smart devices thus overwriting the traditional way.
The rising demand for IoT enabled devices drives the market for switching equipment.In July 2019, Ekinops, a France based leading supplier of telecommunications solutions for telecom operators, acquired OTN-Switch (Optical Transport Network) platform from Padtec, an optical communications system manufacturer based in Brazil for €10 million.
“Global Adaptive Cruise Control (ACC) Systems Market 2025” Report Provides Porters Five Forces Analysis Illustrates the Potency of Buyers & Suppliers Operating in the Industry & the Quantitative Analysis of The Global Market from 2019 to 2025 is Provided to Determine the Market Potential.
Quantitative analysis of the industry from 2014 to 2025 by Region, Type, Application.
Industrial chain,upstream and downstream situation involved in this market.
Request a sample of Adaptive Cruise Control (ACC) Systems Market report @ http://www.arcognizance.com/enquiry-sample/556644
Geographically, global Adaptive Cruise Control (ACC) Systems market competition by top manufacturers, with production, price, revenue (value) and market share for each manufacturer; the top players including
Access this report Adaptive Cruise Control (ACC) Systems Market @ http://arcognizance.com/report/global-adaptive-cruise-control-acc-systems-market-research-report-2019-by-manufacturers-regions-types-and-applications
